RNAC vs AAPL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AAPL has stronger fundamentals based on our AI analysis.

RNAC
Cartesian Therapeutics, Inc.
STRONG SELL
85%
Confidence
VS
AAPL
Apple Inc.
BUY
87%
Confidence

RNAC vs AAPL Fundamental Comparison

Metric RNAC AAPL
Revenue $2.8M $143.8B
Net Income $-130.3M $42.1B
Net Margin -4,658.6% 29.3%
ROE N/A 47.7%
ROA -44.0% 11.1%
Current Ratio 8.65x 0.97x
Debt/Equity N/A 1.00x
EPS $-5.02 $2.84

Green = Better metric | Red = Weaker metric

View Full RNAC Analysis →
View Full AAPL Analysis →

You Might Also Compare

RNAC vs MSFT AAPL vs GOOGL RNAC vs AMZN AAPL vs NVDA

RNAC vs AAPL: Frequently Asked Questions

Is RNAC or AAPL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. RNAC is rated STRONG SELL (85% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.

How does RNAC compare to AAPL fundamentally?

Cartesian Therapeutics, Inc. has ROE of N/A vs Apple Inc.'s 47.7%. Net margins are -4,658.6% vs 29.3% respectively.

Which stock pays higher dividends, RNAC or AAPL?

RNAC has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in RNAC or AAPL for long term?

For long-term investing, consider that RNAC has STRONG SELL rating with 85% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about RNAC vs AAPL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RNAC vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.